|Bid price||995.00||Open price||1,020.00|
|Ask price||1,028.00||Prev close||1,026.00|
Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.
Register now for FREE Dechra Pharmaceuticals share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB0009633180|
|Activites||Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.||Index||FTSE 250|
|Latest Share Price (p)||1,011.50||Net Gearing (%)||17.70|
|Market Capitalisation (£m)||903.43||Gross Gearing (%)||33.42|
|Shares in issue (m)||87.97||Debt Ratio||21.58|
|P/E Ratio||46.39||Debt-to-Equity Ratio||0.55|
|Total dividends per share (p)||16.94||Assets / Equity Ratio||1.50|
|Dividend Yield (%)||1.65||Price to book value||4.65|
|Dividend cover (x)||1.25||ROCE (%)||10.41|
|Earning per share (p)||22.14||EPS Growth (%)||-67.23|
|52 week high / low||1,110.00 / 852.50||DPS Growth (%)||10.00|
|Dec.Date||Type||Director||Pos||No. of Shares|
/* */ RNS Number : 4223O Dechra Pharmaceuticals PLC 08 February 2016 8 February 2016 Dechra ® Pharmaceuticals PLC (Dechra or the Company) Additional Listing ...
/* */ RNS Number : 5159N Dechra Pharmaceuticals PLC 01 February 2016 1 February 2016 Dechra ® Pharmaceuticals PLC (Dechra or the Company) In conformity with DTR 5.6.1R, the...
Dechra Pharmaceuticals reports strang first half trading with revenue growth including Genera, of approximately 15% at constant currencies and 10% at actual exchange rates. Excluding Genera, which was acquired in October, revenue growth was 11% at constant currencies and 7% at actual rate....
Register now for FREE Dechra Pharmaceuticals company news
A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...
Register now for FREE Dechra Pharmaceuticals share price discussions